Orlowski C C, Ooi G T, Rechler M M
Growth and Development Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Mol Endocrinol. 1990 Oct;4(10):1592-9. doi: 10.1210/mend-4-10-1592.
Binding proteins for the insulin-like growth factors (IGFBP) are important modulators of the biological actions of IGF-I and IGF-II. Concentrations of one of these proteins, IGFBP-1, in human plasma and IGFBP-1 mRNA in rat liver are markedly altered in diabetes and fasting. We now examine the regulation of IGFBP-1 and IGFBP-I mRNA in H4-II-E cells, a rat cell line derived from the minimal deviation H35 Reuber hepatoma previously reported to synthesize IGFBP-1 as its predominant IGF-binding protein. Confluent H4-II-E cells in serum-free medium were incubated with different hormones for 48 h, and the conditioned medium was analyzed by ligand blotting. Dexamethasone (10(-6) M) increased levels of 30-kDa IGFBP-1 approximately 10-fold; stimulation was half-maximal at 6 x 10(-9) M dexamethasone. No stimulation was seen with progesterone, testosterone, IGF-I, or rat GH, whereas insulin gave a small inhibition. Immunoblot analysis using a monoclonal antibody to human IGFBP-1 confirmed that the 30-kDa IGFBP induced by dexamethasone was IGFBP-1. IGFBP-1 mRNA was increased to a similar extent (7-fold), as determined by Northern blot hybridization using human or rat IGFBP-1 cDNA probes. The stimulation of IGFBP-1 mRNA was observed within 3 h after the addition of dexamethasone; IGFBP-1 in the medium increased more slowly. After withdrawal of dexamethasone from stimulated cells, IGFBP-1 mRNA decreased by 80% after 48 h; IGFBP-1 decreased more slowly. The increased abundance of IGFBP-1 mRNA in dexamethasone-treated cells primarily reflected increased transcription rather than increased mRNA stability.(ABSTRACT TRUNCATED AT 250 WORDS)
胰岛素样生长因子结合蛋白(IGFBP)是IGF-I和IGF-II生物活性的重要调节因子。糖尿病和禁食时,人血浆中这些蛋白之一的IGFBP-1浓度以及大鼠肝脏中的IGFBP-1 mRNA会发生显著变化。我们现在研究IGFBP-1和IGFBP-1 mRNA在H4-II-E细胞中的调节情况,H4-II-E细胞是一种大鼠细胞系,源自先前报道的以合成IGFBP-1作为其主要IGF结合蛋白的微小偏差H35 Reuber肝癌细胞。将无血清培养基中汇合的H4-II-E细胞与不同激素孵育48小时,并用配体印迹法分析条件培养基。地塞米松(10⁻⁶ M)使30 kDa的IGFBP-1水平增加约10倍;在6×10⁻⁹ M地塞米松时刺激作用达到半数最大效应。孕酮、睾酮、IGF-I或大鼠生长激素未观察到刺激作用,而胰岛素有轻微抑制作用。使用抗人IGFBP-1单克隆抗体的免疫印迹分析证实,地塞米松诱导的30 kDa IGFBP为IGFBP-1。通过使用人或大鼠IGFBP-1 cDNA探针的Northern印迹杂交测定,IGFBP-1 mRNA增加到类似程度(7倍)。添加地塞米松后3小时内观察到IGFBP-1 mRNA的刺激作用;培养基中的IGFBP-1增加得更慢。从受刺激细胞中撤除地塞米松后,48小时内IGFBP-1 mRNA下降80%;IGFBP-1下降得更慢。地塞米松处理细胞中IGFBP-1 mRNA丰度的增加主要反映转录增加而非mRNA稳定性增加。(摘要截短至250字)